Notably, fibrate treatment was previously shown to increase plasma tHcy [39, 40], supporting a possible role of PPARα in the hyperhomocysteinemia in response to TTP treatment. This evidence concerns the gene PPARA and thrombotic thrombocytopenic purpura.